Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model

被引：11
|
作者：
Cha, R
Rybak, MJ
机构：
[1] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Antiinfect Res Lab, Dept Pharm Practice, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Detroit Receiving Hosp, Detroit, MI USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 06期
关键词：
D O I：
10.1128/AAC.47.6.1984-1987.2003
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Potential alternatives, including linezolid, adjunctive rifampin, and moxifloxacin, were evaluated against vancomycin-tolerant (P9802-020) and vancomycin-susceptible clinical isolates of Streptococcus pneumoniae in an in vitro pharmacodynamic model. Vancomycin exhibited maximal killing of 2-log(10) CFU/ml against P9802-020. Linezolid, moxifloxacin, and linezolid plus rifampin exhibited 99.9% killing against both isolates. These alternatives should be considered for further evaluation against vancomycin-tolerant S. pneumoniae.
引用
收藏
页码：1984 / 1987
页数：4
相关论文
共 41 条
  • [1] Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model
    Cha, R
    Akins, RL
    Rybak, MJ
    PHARMACOTHERAPY, 2003, 23 (12): : 1531 - 1537
  • [2] Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model
    Coyle, EA
    Rybak, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 706 - 709
  • [3] KILLING KINETICS OF VANCOMYCIN AND RIFAMPIN TESTED ALONE AND IN COMBINATION AGAINST PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE
    BARAKETT, V
    LESAGE, D
    DELISLE, F
    VERGEZ, P
    PETIT, JC
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (01) : 69 - 71
  • [4] In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
    Tong, Jiepeng
    Jiang, Yiheng
    Xu, Hao
    Jin, Xuehang
    Zhang, Li
    Ying, Shuaibing
    Yu, Wei
    Qiu, Yunqing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3049 - 3055
  • [5] Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic Model
    Lee, Hee Ji
    Bergen, Phillip J.
    Bulitta, Jurgen B.
    Tsuji, Brian
    Forrest, Alan
    Nation, Roger L.
    Li, Jian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (08) : 3738 - 3745
  • [6] Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model
    Jahanbakhsh, Seyedehameneh
    Singh, Nivedita B.
    Yim, Juwon
    Kebriaei, Razieh
    Smith, Jordan R.
    Lev, Katherine
    Tran, T. T.
    Rose, Warren E.
    Arias, Cesar A.
    Rybak, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
  • [7] In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug resistant enterococci
    Messick, CR
    Woodward, J
    Pendland, SL
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (02) : 95 - 99
  • [8] In vitro pharmacodynamic modelling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae
    Zhanel, GG
    Walters, M
    Laing, N
    Hoban, DJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) : 435 - 440
  • [9] In Vitro Antimicrobial Activity of Fosfomycin, Vancomycin and Daptomycin Alone, and in Combination, Against Linezolid-Resistant Enterococcus faecalis
    Wei Yu
    Jiajie Zhang
    Jiepeng Tong
    Li Zhang
    Yaqiong Zhan
    Yicheng Huang
    Yunqing Qiu
    Infectious Diseases and Therapy, 2020, 9 : 927 - 934
  • [10] In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae
    Patel, R
    Rouse, MS
    Piper, KE
    Steckelberg, JM
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (02) : 119 - 122
12345